HAVCR2 and head and neck squamous cell carcinoma: In head and neck squamous cell carcinoma (HNSCC), galectin-9 binding to TIM-3 impairs NK cell-mediated killing by disrupting PI3K signalling while concurrently promoting IFN-γ release in a TIM-3-dependent manner.